Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Atopic Dermatitis
Public ClinicalTrials.gov record NCT03235024. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Vehicle Controlled, Double Blind, Multicenter, Randomized, Phase II Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Mild to Moderate Atopic Dermatitis
Study identification
- NCT ID
- NCT03235024
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- AOBiome LLC
- Industry
- Enrollment
- 122 participants
Conditions and interventions
Conditions
Interventions
- B244 Biological
- Vehicle Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 14, 2018
- Primary completion
- Feb 26, 2019
- Completion
- Mar 19, 2019
- Last update posted
- Oct 9, 2022
2018 – 2019
United States locations
- U.S. sites
- 17
- U.S. states
- 11
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Central Research Associates | Birmingham | Alabama | 35205 | — |
| Elite Clinical Studies | Phoenix | Arizona | 85018 | — |
| Encino Research Center | Encino | California | 91436 | — |
| Orange County Research Center | Tustin | California | 92780 | — |
| Neostart Corporation d.b.a AGA Clinical Trials | Hialeah | Florida | 33012 | — |
| Clinical Neuroscience Solution, Inc | Jacksonville | Florida | 32256 | — |
| FXM Research Corp. | Miami | Florida | 33175 | — |
| FXM Research Miramar | Miramar | Florida | 33027 | — |
| Clinical Neuroscience Solution, Inc | Orlando | Florida | 32801 | — |
| Clinical Research Trials of Florida, Inc. | Tampa | Florida | 33607 | — |
| Columbus Regional Research Institute | Columbus | Georgia | 31904 | — |
| DeNova Research dba Arano, LLC | Chicago | Illinois | 60611 | — |
| Clarkston Skin Research | Clarkston | Michigan | 48349 | — |
| MediSearch Clinical Trials | Saint Joseph | Missouri | 64506 | — |
| LoveLace Scientific Resources | Albuquerque | New Mexico | 87108 | — |
| Central Sooner Research | Norman | Oklahoma | 73071 | — |
| Paddington Testing Co. | Philadelphia | Pennsylvania | 19103 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03235024, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 9, 2022 · Synced May 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03235024 live on ClinicalTrials.gov.